The purpose of this study is to evaluate the efficacy, safety, and tolerability of BMS-986278 in Participants with Progressive Pulmonary Fibrosis.
- Pulmonary Fibrosis
- Lung Diseases, Interstitial
- Arthritis, Rheumatoid
- Connective Tissue Diseases
- Sarcoidosis
- Scleroderma, Diffuse
- Fibrosis
Age: 21 years - 66+
Gender: All